Results · Apr-Jun 2026 · filed 5 Aug 2026
Aster DM Healthcare Q1 FY27 results
Sales grew 22% to ₹1,311 crore from ₹1,078 crore in Apr-Jun 2025.
Operating profit grew 27% to ₹264 crore, an operating margin of 20.2% (up 0.9 points from a year ago).
Net profit fell 69% to ₹29.3 crore from ₹93.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +11%, net profit −81%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 1,311 | 1,078 | +22% |
| Operating profit (EBITDA) | 264.3 | 207.4 | +27% |
| Operating margin | 20.2% | 19.2% | +0.9 pts |
| Net profit | 29.3 | 93.6 | −69% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Aster DM Quality Care's first quarter as a merged entity (from 1 Jul 2026) delivered strong results: combined proforma revenue grew 20% from a year earlier to ₹2,597 crore, EBITDA surged 30% to ₹576 crore with margin expansion of 170 bps to 22.2%. Management expects EBITDA margins of 24%-25% within 2-3 years through synergies & 10%-15% incremental EBITDA from merger benefits.
The last 7 quarters
Filings that week
- 6 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Acquisition
- 5 Aug 2026Outcome Of Board Meeting Held On 5 August 2026 - Others
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 5 Aug 2026Unaudited Financial Results (Standalone And Consolidated) For The First Quarter Ended 30 June 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.